AEROSIL® 200 Pharma is a high purity amorphous anhydrous colloidal silicon dioxide for use in pharmaceutical products whichfulfils the analytical requirements of the currently valid versions of the European Pharmacopeia (Ph. Eur.), United States Pharmacopeia (USP/NF), Japanese Pharmacopeia (JP) and Indian Pharmacopoeia (IP). It is tested and certified according to pharmacopoeia methods. It fulfils purity criteria of E551 according to 231/2012 EU.
In our production location in Rheinfelden, Germany AEROSIL® 200 Pharma is manufactured and packaged according to IPEC/GMP and HACCP/FAMI-QS guidelines. The production and packaging process has been audited and fulfills the requirements of regulation EC No. 852/2004.
TAMC (total aerobic microbial count) , TYMC (total combined yeast and mould count) and Gram-negative bacteria are tested on a regular basis acc. to USP and IP.
Scope of Application
Pharmacy, all types of dosage forms
Free flow and anti-caking agent to improve powder properties
Improves tablet properties such as hardness and friability
Used as viscosity increasing agent to thicken and thixotropize liquids
Dessicant for moisture-sensitive actives
Improves distribution of active pharmaceutical ingredients
Used as anti-setting, thickening and anti-sagging agent
High purity, low humidity content
No influence on taste
Does not alter natural colour of powder formulations